Immunosignaturing Can Detect Products from Molecular Markers in Brain Cancer

Immunosignaturing shows promise as a general approach to diagnosis. It has been shown to detect immunological signs of infection early during the course of disease and to distinguish Alzheimer’s disease from healthy controls. Here we test whether immunosignatures correspond to clinical classificatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Hughes, Alexa K., Cichacz, Zbigniew, Scheck, Adrienne, Coons, Stephen W., Johnston, Stephen Albert, Stafford, Phillip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397978/
https://www.ncbi.nlm.nih.gov/pubmed/22815729
http://dx.doi.org/10.1371/journal.pone.0040201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397978/
https://www.ncbi.nlm.nih.gov/pubmed/22815729
http://dx.doi.org/10.1371/journal.pone.0040201

Ejemplares similares